I-BET432
Product Specifications
Target
Others|||Epigenetic Reader Domain
Related Pathways
Chromatin/Epigenetic|||Others
Bioactivity
I-BET432, a BET inhibitor, targets both the N-terminal (BD1) and C-terminal (BD2) bromodomains of BRD4, exhibiting pIC50 values of 7.5 and 7.2, respectively. As an orally administered candidate, I-BET432 holds potential for research in various oncology and inflammatory diseases.
Smiles
C[C@@H]1C2=C(C=C(C=C2)[C@H](CO)O)C(=CN(C1=O)C)C3=CN(N=C3)C
Molecular Formula
C18H21N3O3
Molecular Weight
327.38
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15086455 1 Vial
Lentiviral human PRAMEF14 shRNA (UAS) - Lentiviral human PRAMEF14 shRNA (UAS) plasmid
Ask
View Details